Which blood thinner works best for APS patients? new study aims to find out

NCT ID NCT07372170

Recruiting now Knowledge-focused Sponsor: Infanta Leonor University Hospital Source: ClinicalTrials.gov ↗

First seen Jan 31, 2026 · Last updated Apr 30, 2026 · Updated 12 times

Summary

This study looks at two types of blood thinners (DOACs and VKAs) to see which is better at preventing repeat blood clots in people with a low-risk form of antiphospholipid syndrome (APS). APS is an autoimmune condition that raises the risk of dangerous clots. The study will follow 600 adults already taking one of these medications as part of their normal care and track how many have another clot or a bleeding problem. The goal is to provide clearer guidance on the best treatment option for these patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME (APS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Hospital Universitario Infanta Leonor
RECRUITING

Madrid, Madrid, 28031, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hospital Universitario Infanta Sofía
RECRUITING

Madrid, Madrid, Spain

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ANTIPHOSPHOLIPID SYNDROME (APS) THROMBOPHILIA VENOUS THROMBOSIS (DISORDER)